1.190USD+12.80%Mkt Cap: 66.14M USDP/E: —Last update: 2026-06-01
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies in the United States. The company's lead product candidate is PDS0101, a Versamune HPV, …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap66.14M USD
Enterprise Value50.49M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-34.50M USD
Revenue/Share—
Last Price1.190 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees21
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS70465T1079
Valuation
P/E (Trailing)—
P/E (Forward)-2.31
PEG—
EV/EBITDA-1.75
EV/Revenue—
P/S—
P/B6.39
EPS (TTM)-0.66
EPS (Forward)-0.47
52W Range
0.507049% of range1.915
52W High1.915 USD
52W Low0.5070 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-372.85%
ROA-113.12%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-27.75M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-9.79M USD
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity1.83
Current Ratio—
Quick Ratio—
Book Value/Sh0.1690 USD
Cash/Share0.4790 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 18, 2019
Splits
Last Split1:20
Split DateMar 18, 2019
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)7.500 USD
Target Range3.000 USD – 15.00 USD
# Analysts3
Ownership
Shares Out.55.82M
Float54.40M
Insiders1.51%
Institutions9.16%
Short Interest
Short Ratio1.6d
Short % Float3.42%
Short % Out.3.31%
Shares Short1.85M
Short (prev mo.)1.72M
Technical
SMA 500.9927 (+19.9%)
SMA 2000.9412 (+26.4%)
Beta1.50
S&P 52W Chg27.70%
Avg Vol (30d)1.01M
Avg Vol (10d)1.29M
Technical Indicators
RSI (14)47.5
MACD0.0200
MACD Signal0.0440
MACD Hist.-0.0240
BB Upper1.401 USD
BB Middle1.148 USD
BB Lower0.8959 USD
BB Width43.97%
ATR (14)0.1493 USD
Vol Ratio (20d)0.64x